您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Endomorphin 2(trifluoroacetate salt)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Endomorphin 2(trifluoroacetate salt)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Endomorphin 2(trifluoroacetate salt)图片
规格:98%
分子量:571.7
包装与价格:
包装价格(元)
1mg电议
5mg电议

产品介绍
Endomorphin 2 is an endogenous neuropeptide and μ-opioid receptor agonist (Ki = 0.69 nM) that has analgesic, negative reinforcing, and gastrointestinal properties.
货号:ajcx18430
CAS:N/A
分子式:C32H37N5O5•XCF3COOH
分子量:571.7
溶解度:1mg/mL in water
纯度:98%
存储:Store at -20°C
库存:现货

Background:

Endomorphin 2 is an endogenous neuropeptide and μ-opioid receptor agonist (Ki = 0.69 nM) that has analgesic, negative reinforcing, and gastrointestinal properties.[1][2] It is found in the spinal cord and, to a lesser extent, in the brain. [3]? It is selective for μ- over δ- and κ-opioid receptors (Kis = 9,233 and 5,240 nM, respectively). [1] Endomorphin 2 also binds to mouse brain membranes and rat recombinant μ-opioid receptors expressed in CHO cells (Kis = 1.37 and 0.58 nM, respectively).[2] It inhibits cAMP accumulation induced by forskolin in CHO cells expressing rat recombinant μ-opioid receptors and in SH-SY5Y human neuroblastoma cells (IC50s = 7.08 and 7.76 nM, respectively).[4]? In mice, endomorphin 2 increases analgesia in a radiant heat tail-flick assay in mice following intracerebroventricular (i.c.v.) or intrathecal administration (ED50s = 1.99 and 3.81 μg, respectively) and induces conditioned place aversion when administered intracerebroventricularly at a dose of 10 μg. [2]It also decreases gastrointestinal transit time in mice when administered intracerebroventricularly at a dose of 3 μg.[2]

参考文献:
[1]. Zadina, J.E., Hackler, L., Ge, L.J., et al. A potent and selective endogenous agonist for the μ-opiate receptor. Nature 386(6624), 499-502 (1997).
[2]. Goldberg, I.E., Rossi, G.C., Letchworth, S.R., et al. Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain. J. Pharmacol. Exp. Ther. 286(2), 1007-1013 (1998).
[3]. Martin-Schild, S., Gerall, A.A., Kastin, A.J., et al. Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. J. Comp. Neurol. 405(4), 450-471 (1999).
[4]. Harrison, C., McNulty, S., Smart, D., et al. The effects of endomorphin-1 and endomorphin-2 in CHO cells expressing recombinant μ-opioid receptors and SH-SY5Y cells. Br. J. Pharmacol. 128(2), 472-478 (1999).